Publications

5600 Results

Supplement use and chemotherapy-induced peripheral neuropathy in breast cancer patients treated on SWOG study S0221

Authors
G Zirpoli;S McCann;L Sucheston-Campbell;D Hershman;G Ciupak;W Davis;J Unger;H Moore;J Stewart;C Isaacs;T Hobday;M Salim;R Livingston;G Hortobagyi;D Hayes;G Budd;K Albain;C Ambrosone
Journal / Conference
American Association for Research Annual Meeting (April 16 - 20, 2016, New Orleans, LA), abst #3413, poster
Year
2016
Research Committee(s)
Breast
Study Number(s)
S0221

Molecular characterization of follicular lymphoma patients enrolled on SWOG S0016 using FFPE Chromosomal Genomic Array Testing

Authors
X Qu;H Li;O Press;L Rimsza;R Braziel;M Leblanc;E Hsi;S Smith;J Friedberg;M Fang
Journal / Conference
Annual Clinical Genetics Meeting of the American College of Medical Genetics and Genomics ( March 8-12, 2016, Tampa, FL), poster, abst #141 (https://acmg.expoplanner.com/index.cfm?do=expomap.sess&event_id=7&session_id=1668)
Year
2016
Research Committee(s)
Lymphoma
Study Number(s)
S0016

Variants associated with high grade bevacizumab-induced hypertension identified by exome sequencing: CALGB 80405 (Alliance).

Authors
M Li;F Mulkey;C Jiang;B O'Neil;D Niedzwiecki;P Friedman;H Hochster;H Lenz;A Venook;K Owzar;D Kroetz
Journal / Conference
American Society for Clinical Pharmacology and Therapeutics (March 8-12, San Diego, CA), late breaking poster session abst. #LB-041, p. 164
Year
2016
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

Authors
D Hershman;C Till;J Wright;D Awad;S Ramsey;W Barlow;L Minasian;J Unger
Journal / Conference
Journal of Clinical Oncology Sep 1;34(25):3014-3022; 2016 Jun 20 [Epub ahead of print]
Year
2016
Research Committee(s)
Breast, Genitourinary, Gynecologic, Head and Neck, and Lung
PMID
PMID27325863
PMC
PMC5012713
Study Number(s)
S0003, S0007, S0009, S0012, S0022, S0023, S0027, S0028, S0029, S0032, S0102, S0219, S0221, S0329, S0421, S0536, S0819, S9712, S9900, S9902, S9912, S9914, S9916

Long-term consequences of intervention following receipt of finasteride or placebo in the Prostate Cancer Prevention Trial (SWOG S9217)

Authors
J Unger;C Till;I Thompson;C Tangen;P Goodman;J Wright;W Barlow;S Ramsey;L Minasian;D Hershman
Journal / Conference
Journal of the National Cancer Institute Aug 26;108(12). pii: djw168. doi: 10.1093/jnci/djw168.
Year
2016
Research Committee(s)
Cancer Control
PMID
PMID27565902
PMC
PMC5241895
Study Number(s)
SWOG-9217

Peripheral zone inflammation is not strongly associated with lower urinary tract symptom incidence and progression in the placebo arm of the Prostate Cancer Prevention Trial

Authors
I Kulac;B Gumuskaya;C Drake;B Gonzalez;K Arnold;P Goodman;A Kristal;MS Lucia;IM Thompson;WB Isaacs;AM De Marzo;E Platz
Journal / Conference
Prostate Nov;76(15):1399-1408; 2016 Jun 21 [Epub ahead of print]
Year
2016
Research Committee(s)
Cancer Control
PMID
PMID27325488
PMC
PMC5497457
Study Number(s)
SWOG-9217

A meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer

Authors
S Halabi;W Kelly;H Ma;H Zhou;N Solomon;K Fizazi;C Tangen;M Rosenthal;D Petrylak;M Hussain;N Vogelzang;IM Thompson;KN Chi;J de Bono;A Armstrong;M Eisenberger;A Fandi;S Li;JC Araujo;C Logothetis;D Quinn;M Morris;C Higano;I Tannock;E Small
Journal / Conference
Journal of Clinical Oncology May 10;34(14):1652-1659
Year
2016
Research Committee(s)
Genitourinary
PMID
PMID26951312
PMC
PMC4872320
Study Number(s)
S0421, S9916

Biases in recommendations for and acceptance of prostate biopsy significantly affect assessment of prostate cancer risk factors. Results from two large randomized clinical trials

Authors
C Tangen;P Goodman;C Till;J Schenk Kisser;MS Lucia;IM Thompson
Journal / Conference
Journal of Clinical Oncology Dec 20;34(36):4338-4344. Epub 2016 Oct 28
Year
2016
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
PMID
PMID27998216
PMC
PMC5455311
Study Number(s)
S0000, SWOG-9217

Validation of the association of RECIST 1.0 changes with survival in men with metastatic castration resistant prostate cancer (mCRPC) treated on SWOG study S0421

Authors
G Pond;G Sonpavde;M Plets;C Tangen;M Hussain;P Lara;A Goldkorn;M Garzotto;C Higano;N Vogelzang;IM Thompson;P Twardowski;P Van Veldhuizen;N Agarwal;M Carducci;JP Monk;DI Quinn
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr 5079) American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), poster session
Year
2016
Research Committee(s)
Genitourinary
Study Number(s)
S0421

Outcomes for patients treated with or without bevacizumab on SWOG S0819: a randomized, phase III study comparing carboplatin/paclitaxel or carboplatin/paclitaxel/bevacizumab with or without concurrent cetuximab in patients with advanced non-small cell lung cancer (NSCLC)

Authors
T Semrad;M Redman;R Herbst;ES Kim;L Bazhenova;G Masters;K Oettel;P Guaglianone;C Reynolds;A Karnad;S Arnold;M Varella Garcia;J Moon;P Mack;C Blanke;FR Hirsch;K Kelly;D Gandara
Journal / Conference
Journal of Clinical Oncology 34, 2016 (supp;abstr 9082);American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), poster session
Year
2016
Research Committee(s)
Lung
Study Number(s)
S0819